Actively Recruiting

Age: 18Years +
All Genders
ID07311135

Accuracy of Wrist-worn Pulse Oximeter SpO2 Measurements in Patients Diagnosed With Pulmonary Hypertension

Led by Golden Jubilee National Hospital · Updated on 2026-02-17

20

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating how accurately smartwatches can measure oxygen levels in people with pulmonary hypertension, a condition affecting blood pressure in the lungs. This pilot study compares smartwatch oxygen readings to those from a finger probe and arterial blood samples taken from the wrist. The main focus is on measuring oxygen while resting, after exercise, and during a controlled low oxygen breathing test. During a single hospital visit lasting about three hours, participants will undergo several tests. These include a six-minute walk test to measure oxygen after exercise and a hypoxic challenge where they breathe air with reduced oxygen through a mask. Arterial blood samples, smartwatch readings, and finger pulse oximeter data will be collected at rest, after exercise, and during the hypoxic challenge to compare accuracy. Participants will have an arterial line placed for blood sampling and will be monitored for safety during and after testing. All data will be anonymized and securely stored. The study aims to recruit about 20 patients diagnosed with pulmonary hypertension who can perform the walk test and provide informed consent. Researchers will analyze how closely smartwatch measurements match the gold standard arterial oxygen levels.

CONDITIONS

Brief Title

Accuracy of Smartwatches in Measuring Oxygen Levels in Patients With Pulmonary Hypertension: A Pilot Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 18 years and older
  • Diagnosed with pulmonary hypertension by right heart catheterisation showing baseline mean pulmonary artery pressure > 20mmHg and pulmonary vascular resistance > 2 Woods Units
  • Able to perform a six-minute walk test
  • Able to give written informed consent
Not Eligible

You will not qualify if you...

  • Peripheral arterial disease
  • Tattoos or skin markings covering the dorsal wrist
  • Resting oxygen saturation (SpO2) less than 88%
  • Severe medical conditions preventing participation or with life expectancy less than 3 months
  • Patients with bleeding disorders
  • Patients on anticoagulation except those on anticoagulation solely for pulmonary arterial hypertension long term survival benefit, who may stop anticoagulation for 1 week before the study visit if they choose

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) at outpatient clinic for eligibility screening and study information

Diagnostic Evaluation

Duration - Approximately 3 hours

Participants undergo a single study visit where oxygen saturation measurements are taken using a wrist-worn pulse oximeter, arterial blood gas sampling via an arterial line, and a finger probe pulse oximeter at rest, after exercise, and during a hypoxic challenge.

1 study visit (in-person) including arterial line insertion, six-minute walk test, hypoxic challenge, and monitoring

Monitoring

Duration - 30 minutes

Participants are monitored for 30 minutes after arterial line removal to ensure safety before leaving the study visit.

Post-procedure monitoring during the same study visit

Trial Site Locations

Total: 1 location

1

Golden Jubilee National Hospital

Glasgow, United Kingdom, G81 4DY

Actively Recruiting

Loading map...

Research Team

M

Martin Johnson, BA, MBChB(Hons), MD, FRCP

J

Jamie Ingram, MBChB, BMSc, PGCert

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

129Xenon MR Imaging and Spectroscopy Response to Sotatercept...

Pulmonary Hypertension

Actively Recruiting

1 location

An Open-Label, Phase 2 Study Evaluating the Safety of Moslic...

Pulmonary Hypertension

Actively Recruiting

1 location

A Phase 2, Double-blind, Randomized, Placebo-Controlled Stud...

Pulmonary Hypertension

Actively Recruiting

86 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Assessment of Non-Invasive Measurements of Oxygen Saturation and Heart Rate with an Apple Smartwatch: Comparison with a Standard Pulse Oximeter.

Carmen Spaccarotella, Alberto Polimeni, Cinzia Mancuso...

https://pubmed.ncbi.nlm.nih.gov/35329793

Comparison of SpO2 and heart rate values on Apple Watch and conventional commercial oximeters devices in patients with lung disease.

Leonardo Zumerkorn Pipek, Rafaela Farias Vidigal Nascimento, Milena Marques Pagliarelli Acencio...

https://pubmed.ncbi.nlm.nih.gov/34556765